Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1989-06-29
1991-04-23
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514445, 514447, 514448, 514457, 514471, 514472, 514480, 514507, 514581, 514586, 514590, 514595, 514602, 514604, 514605, 514693, 549 65, 549 66, 549 69, 549 72, 549399, 549404, 549405, 549479, 549480, 549487, 549488, 558233, 558239, 560 10, 560312, 560314, 560315, 560 24, 560 32, 560 34, 560 42, 562427, 562439, 562451, A61K 31235, A61K 3119, C07C 69616
Patent
active
050101048
ABSTRACT:
Novel tricyclic compounds having a TXA.sub.2 -antagonizing activity represented by formul (I): ##STR1## which strongly antagonize an action of thromboxane A.sub.2 and are expected to have preventive and therapeutic effects on ischemica diseases, cerebro-vascular diseases, etc.
REFERENCES:
patent: 3354155 (1967-11-01), Tretter
patent: 3372196 (1968-03-01), Engelhardt
patent: 3420851 (1969-01-01), Bloom et al.
patent: 3631103 (1971-12-01), Rey-Bellet
patent: 4282365 (1981-08-01), Rokach et al.
patent: 4396550 (1983-08-01), Takizawa et al.
patent: 4465835 (1984-08-01), Takizawa et al.
patent: 4585788 (1986-04-01), Helsley et al.
patent: 4596804 (1986-06-01), Takizawa et al.
patent: 4749703 (1988-06-01), Uno et al.
patent: 4835179 (1989-05-01), Cirera et al.
Arz.-Forsch., 13, 1039 (1963).
Arz.-Forsch., 14, 100 (1964).
J. Med. Chem. 19, 941 (1976), Ueno et al.
J. Med. Chem. 20, 1499 (1977), Aultz et al.
J. Med. Chem. 21, 633 (1978), Yoshioka et al.
Drugs, 13, 161 (1977), Pinder et al.
Ishii Akio
Karasawa Akira
Kubo Kazuhiro
Miki Ichiro
Obase Hiroyuki
Brust Joseph Paul
Haley Jacqueline
Kyowa Hakko Kogyo Co. Ltd.
LandOfFree
Tricyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1621740